ImmunoRx Pharma, Inc.
Pharmaceutical company · Wilmington, Delaware, United States
ImmunoRx Pharma, Inc. is a pharmaceutical company headquartered in Wilmington, Delaware, United States. Its earliest recorded incorporation is in 2020. It has reported private securities offerings to the US SEC, most recently $2.7 million sold in a notice filed in 2021.
ImmunoRx Pharma at a glance
What does ImmunoRx Pharma do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $2.7 million sold (2021).
Frequently asked questions about ImmunoRx Pharma
Where is ImmunoRx Pharma headquartered?
ImmunoRx Pharma, Inc. is headquartered in Wilmington, Delaware, United States.
What does ImmunoRx Pharma do?
ImmunoRx Pharma, Inc. is a pharmaceutical company.
When was ImmunoRx Pharma founded?
The earliest incorporation on record for ImmunoRx Pharma, Inc. is in 2020, according to public company registers.
Similar companies
- Prelude Therapeutics IncWilmington, Delaware, United States
- Dusa Pharmaceuticals IncWilmington, Massachusetts, United States
- NeuroRx, Inc.Wilmington, Delaware, United States
- NRX Pharmaceuticals, Inc.Wilmington, Delaware, United States
- Applied Molecular Transport Inc.Wilmington, Delaware, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences